AAAAAA
Results:
1-15
|
Results: 15
Authors:
Sandres, K
Dubois, M
Pasquier, C
Puel, J
Izopet, J
Citation: K. Sandres et al., Determination of HCV genotype using two antibody assays and genome typing, EUR J CL M, 20(9), 2001, pp. 666-669
Authors:
Pasquier, C
Millot, N
Njouom, R
Sandres, K
Cazabat, M
Puel, J
Izopet, J
Citation: C. Pasquier et al., HIV-1 subtyping using phylogenetic analysis of pol gene sequences, J VIROL MET, 94(1-2), 2001, pp. 45-54
Authors:
Malavaud, S
Malavaud, B
Sandres, K
Durand, D
Marty, N
Icart, J
Rostaing, L
Citation: S. Malavaud et al., Nosocomial outbreak of influenza virus A (H3N2) infection in a solid organtransplant department, TRANSPLANT, 72(3), 2001, pp. 535-537
Authors:
Izopet, J
Massip, P
Souyris, C
Sandres, K
Puissant, B
Obadia, M
Pasquier, C
Bonnet, E
Marchou, B
Puel, J
Citation: J. Izopet et al., Shift in HIV resistance genotype after treatment interruption and short-term antiviral effect following a new salvage regimen, AIDS, 14(15), 2000, pp. 2247-2255
Authors:
Lesourd, F
Izopet, J
Mervan, C
Payen, JL
Sandres, K
Monrozies, X
Parinaud, J
Citation: F. Lesourd et al., Transmissions of hepatitis C virus during the ancillary procedures for assisted conception, HUM REPR, 15(5), 2000, pp. 1083-1085
Authors:
Salama, G
Rostaing, L
Sandres, K
Izopet, J
Citation: G. Salama et al., Hepatitis C virus infection in French hemodialysis units: A multicenter study, J MED VIROL, 61(1), 2000, pp. 44-51
Authors:
Rostaing, L
Izopet, J
Sandres, K
Cisterne, JM
Puel, J
Durand, D
Citation: L. Rostaing et al., Changes in hepatitis C virus RNA viremia concentrations int long-term renal transplant patients after introduction of mycophenolate mofetil, TRANSPLANT, 69(5), 2000, pp. 991-994
Authors:
Sandres, K
Dubois, M
Pasquier, C
Payen, JL
Alric, L
Duffaut, M
Vinel, JP
Pascal, JP
Puel, J
Izopet, J
Citation: K. Sandres et al., Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy, J VIROLOGY, 74(2), 2000, pp. 661-668
Authors:
Izopet, J
Rostaing, L
Sandres, K
Cisterne, JM
Pasquier, C
Rumeau, JL
Duffaut, M
Durand, D
Puel, J
Citation: J. Izopet et al., Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients, J INFEC DIS, 181(3), 2000, pp. 852-858
Authors:
Alric, L
Izopet, J
Fort, M
Vinel, JP
Fontenelle, P
Orfila, C
Payen, JL
Sandres, K
Desmorat, H
Charlet, JP
Duffaut, M
Abbal, M
Citation: L. Alric et al., Study of the association between major histocompatibility complex class IIgenes and the response to interferon alpha in patients with chronic hepatitis C infection, HUMAN IMMUN, 60(6), 1999, pp. 516-523
Authors:
Pasquier, C
Sandres, K
Salama, G
Puel, J
Izopet, J
Citation: C. Pasquier et al., Using RT-PCR and bDNA assays to measure non-clade BHIV-1 subtype RNA, J VIROL MET, 81(1-2), 1999, pp. 123-129
Authors:
Izopet, J
Bicart-See, A
Pasquier, C
Sandres, K
Bonnet, E
Marchou, B
Puel, J
Massip, P
Citation: J. Izopet et al., Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine, J MED VIROL, 59(4), 1999, pp. 507-511
Authors:
Izopet, J
Pasquier, C
Sandres, K
Puel, J
Rostaing, L
Citation: J. Izopet et al., Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit, J MED VIROL, 58(2), 1999, pp. 139-144
Authors:
Izopet, J
Sailler, L
Sandres, K
Pasquier, C
Bonnet, E
Aquilina, C
Puel, J
Massip, P
Marchou, B
Citation: J. Izopet et al., Intermittent selection pressure with zidovudine plus zalcitabine treatmentreduces the emergence in vivo of zidovudine resistance HIV mutations, J MED VIROL, 57(2), 1999, pp. 163-168
Authors:
Izopet, J
Salama, G
Pasquier, C
Sandres, K
Marchou, B
Massip, T
Puel, J
Citation: J. Izopet et al., Decay of HIV-1 DNA in patients receiving suppressive antiretroviral therapy, J ACQ IMM D, 19(5), 1998, pp. 478-483
Risultati:
1-15
|